-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Yoshimoto worked with Eunhee Chung, an associate professor in the Department of Kinesiology at UTSA's College of Health, Community and Policy, to test the new drug
"I've always dreamed of helping my family members who are affected by obesity, heart disease and other diseases
"As an exercise physiologist, I firmly believe that exercise is the best medicine against non-communicable diseases," Chung added
UTSA's drug has the potential to stop the activity of P450 8B1, an enzyme that produces bile acid in the body
The team's study involved treating mice with inhibitor drugs for seven days
Yoshimoto and Chung's work represents UTSA's mission to develop solutions to complex challenges to improve the health and well-being of society
According to the World Health Organization, 1.
"These results suggest that our research in synthetic chemistry can make a significant contribution to societal well-being by treating obesity and heart disease," Yoshimoto said
Journal Reference :
Eunhee Chung, Samuel D.